Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
JINGHAO Partners with Fosun Trade for Hearing Aids in the Global Area 2023-03-23 15:10
111, Inc. Announces Fourth Quarter and Fiscal Year 2022 Financial Results 2023-03-23 14:17
Launching an Innovative Product, PlaClin-M, for Safe Environments in the Pandemic Era. 2023-03-23 13:00
Asia-focused digital mental health company ThoughtFull raises US$4 million in Pre-Series A round, led by Temasek-owned Sheares Healthcare Group 2023-03-23 10:00
Transcenta to Present Two Preclinical Studies at AACR 2023 2023-03-23 08:00
Transcenta Announces First Patient Dosed in the U.S. Study of Its First-In-Class Gremlin1 Targeting Antibody TST003 for the Treatment of Solid Tumors 2023-03-23 08:00
Aquavit Awarded 10M in Damages on Intellectual Property Against Counterfeiters 2023-03-23 01:25
Ascentage Pharma Announces 2022 Annual Results Including Strong Sales of Olverembatinib and Steady Progress in Transition Towards Biopharma 2023-03-23 00:22
Jacobio Pharma Announces 2022 Annual Results 2023-03-22 22:38
Daewoong Pharmaceutical's Envlo to enter the global market in full swing with filing for product license in three ASEAN countries 2023-03-22 21:20
Jolly Good and Harvard University Hospital collaborate on medical VR - Full-scale entry into the U.S. market 2023-03-22 21:00
CARsgen Announced 2022 Annual Results and Business Updates 2023-03-22 20:50
Biosion bispecific antibody therapies to be featured at the American Association for Cancer Research (AACR) annual meeting 2023 2023-03-22 20:19
Turacoz's Research & Trainings Empowering Healthcare Professionals with Enhanced Publication Skills 2023-03-22 20:10
WuXi Biologics Reports Remarkable 2022 Annual Results 2023-03-22 20:09
VRWorkout Launches a Future-of-Fitness Experience, Revolutionizing Workouts with Controller-Free Gameplay 2023-03-22 20:00
Dignitana enters Hong Kong market with leading distributor Science International Corporation 2023-03-22 17:09
Zylox-Tonbridge Assisted Turkish Hospitals in Post-earthquake Recovery 2023-03-22 15:26
Jacobio announces clinical collaboration to evaluate CD73 monoclonal antibody JAB-BX102 in combination with KEYTRUDA® (pembrolizumab) for patients with cancer 2023-03-22 12:36
3SBio announces 2022 annual results, with revenue rising 7.5% year on year and normalized net profit attributable to parents jumping 25.2% 2023-03-22 11:15
1 253 254 255 256 257 1594